Survival analysis in second-line and third-line chemotherapy with irinotecan followed by topotecan or topotecan followed by irinotecan for extensive-stage small-cell lung cancer patients: a single-center retrospective study

PURPOSE: The number of patients who make it to receive third-line chemotherapy is increasing owing to the improvements in adverse-event management of chemotherapy for small-cell lung cancer (SCLC). Sequencing of optimal treatment for SCLC is still a challenge for oncologists. In this paper, we aim t...

Descripción completa

Detalles Bibliográficos
Autores principales: Aktas, Gokmen, Kus, Tulay, Kalender, Mehmet Emin, Sevinc, Alper, Camci, Celaletdin, Kul, Seval
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824370/
https://www.ncbi.nlm.nih.gov/pubmed/27099522
http://dx.doi.org/10.2147/OTT.S101390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824370/
https://www.ncbi.nlm.nih.gov/pubmed/27099522
http://dx.doi.org/10.2147/OTT.S101390

Ejemplares similares